Iodoquinol: Difference between revisions

Jump to navigation Jump to search
Line 31: Line 31:


==Mechanisms of Action==
==Mechanisms of Action==
Iodoquinol acts by [[chelation]] of [[ferrous ion]]s essential for metabolism.<ref>{{cite web|url=http://web.gideononline.com/web/therapy/index.php?type=drugs&code=20130&view=General |work=Gideon Online}}</ref>
Iodoquinol acts by [[chelation]] of Fe<sup>2+</sup> essential for metabolism.<ref>{{cite web|url=http://web.gideononline.com/web/therapy/index.php?type=drugs&code=20130&view=General |work=Gideon Online}}</ref>


==References==
==References==

Revision as of 19:30, 23 December 2013

Iodoquinol
YODOXIN® Package Insert
Description
Inactive Ingredients
Action
Indications
Contraindications
Warnings
Use in Pregnancy
Precautions
Adverse Reactions
Dosage and Administration
How Supplied
Storage

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The quinoline derivative diiodohydroxyquinoline (INN) or iodoquinol (USAN), can be used in the treatment of amoebiasis.[1] It is poorly absorbed from the gastrointestinal tract and is used as a luminal amebicide. It was discovered by Adco Co. and introduced as diiodohydroxyquinoline.[2] Susceptibility of Dientamoeba fragilis has been measured.[3]

Category

Amebicide

US Brand Names

ALA-SEPTIC®, ALCORTIN®, ALCORTIN A®, ALOQUIN®, DERMAZENE®, HYDROCORTISONE IODOQUINOL cream®, VYTONE cream®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Other Size Packages Available | Labels and Packages

Mechanisms of Action

Iodoquinol acts by chelation of Fe2+ essential for metabolism.[4]

References

  1. Ghaskadbi S, Vaidya VG (1989). "In vivo antimutagenic effect of ascorbic acid against mutagenicity of the common antiamebic drug diiodohydroxyquinoline". Mutat. Res. 222 (3): 219–22. doi:10.1016/0165-1218(89)90137-7. PMID 2493578. Unknown parameter |month= ignored (help)
  2. Page 1312. http://books.google.co.in/books?id=TIu28TH_iAYC&printsec=frontcover&source=gbs_ge_summary_r&cad=0#v=onepage&q&f=false
  3. Chan FT, Guan MX, Mackenzie AM, Diaz-Mitoma F (1994). "Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole". Antimicrob. Agents Chemother. 38 (5): 1157–60. PMC 188168. PMID 8067755. Unknown parameter |month= ignored (help)
  4. Gideon Online http://web.gideononline.com/web/therapy/index.php?type=drugs&code=20130&view=General. Missing or empty |title= (help)